1 : -1 Very interesting post hoc analysis of ADJUST-T1D trial just published in Diabetes Care by Kagan Ege Karakus and colleagues
How GLP-1 and Dual GIP/GLP-1 Agonists Work to Treat Obesity GLP-1 agonists and dual GIP/GLP-1 agonists are medications that increase satiety (the feeling of fullness), slow digestion, and quiet constant thoughts about food (known as food noise), making it easier to lose weight and keep it off
Split daily totals across meals
Selection bias, regression to the mean, the placebo effect, and the simultaneous behavioural changes that often accompany a clinic visit (renewed attention to diet, restored adherence to protocols, increased motivation) all confound the interpretation of clinical-observation reports of this kind
7. Mechanism of Action: The GLP-1 Science 8. Safety & Lifestyle Advice 9. Management of Missed Dose 10. Related Products & Alternative Care 11. Quick Storage & Injection Tips 12. Clinical Fact Box 13. Managing Key Patient Concerns 14. User Feedback & Insights 15. Frequently Asked Questions (FAQs) 16. Regulatory Disclaimer & References
We provide the data to help you have a more productive conversation with your medical professional